6.62

2.22% -0.15

Aligos Therapeutics Inc (ALGS)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt ALGS? Forum Prognose

Schlusskurs vom Vortag:

$6.77

Offen:

$6.84

24-Stunden-Volumen:

109.33K

Relative Volume:

0.41

Marktkapitalisierung:

$40.97M

Einnahmen:

$4.71M

Nettoeinkommen (Verlust:

$-90.32M

KGV:

-0.7606

EPS:

-8.7032

Netto-Cashflow:

$-85.19M

1W Leistung:

+18.43%

1M Leistung:

+28.29%

6M Leistung:

-26.44%

1J Leistung:

-24.69%

1-Tages-Spanne:

$6.34

$6.85

1-Wochen-Bereich:

$5.44

$7.08

52-Wochen-Spanne:

$4.80

$13.69

Aligos Therapeutics Inc Stock (ALGS) Company Profile

Firmenname

Aligos Therapeutics Inc

Sektor

Healthcare (1096)

Branche

Biotechnology (616)

Telefon

(800) 466-6059

Adresse

ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO

Mitarbeiter

Twitter

Nächster Verdiensttermin

2026-08-05

Neueste SEC-Einreichungen

ALGS's Discussions on Twitter

Compare ALGS vs VRTX, REGN, ARGX, ALNY, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ALGS Aligos Therapeutics Inc	6.62	40.97M	4.71M	-90.32M	-85.19M	-8.7032
VRTX Vertex Pharmaceuticals Inc	485.39	123.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	664.52	69.67B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.62	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	298.76	39.89B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	186.88	39.73B	742.00K	-1.37B	-1.07B	-7.0731

Aligos Therapeutics Inc Stock (ALGS) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-03-19	Fortgesetzt	Jefferies	Buy
2025-08-18	Fortgesetzt	H.C. Wainwright	Buy
2024-08-19	Eingeleitet	H.C. Wainwright	Buy
2023-01-06	Hochstufung	Jefferies	Hold → Buy
2023-01-06	Hochstufung	Piper Sandler	Neutral → Overweight
2022-03-23	Herabstufung	Piper Sandler	Overweight → Neutral
2022-01-07	Herabstufung	JP Morgan	Overweight → Neutral
2022-01-06	Herabstufung	Jefferies	Buy → Hold
2021-09-09	Eingeleitet	SVB Leerink	Outperform
2021-05-17	Fortgesetzt	Piper Sandler	Overweight
2020-11-10	Eingeleitet	Cantor Fitzgerald	Overweight
2020-11-10	Eingeleitet	JP Morgan	Overweight
2020-11-10	Eingeleitet	Jefferies	Buy
2020-11-10	Eingeleitet	Piper Sandler	Overweight

Alle ansehen

Aligos Therapeutics Inc Aktie (ALGS) Neueste Nachrichten

Jul 09, 2026

ALGS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Jul 09, 2026

ALGS Stock Rallies 16% After-Hours On $25M Cash Boost From China Hepatitis B Drug Deal - Stocktwits

Jul 09, 2026

Jul 08, 2026

ALGS stock rallies 16% after-hours on $25M cash boost from China hepatitis B drug deal - MSN

Jul 08, 2026

H.C. Wainwright reiterates Aligos Therapeutics stock rating at buy - Investing.com

Jul 08, 2026

Analysts Offer Insights on Healthcare Companies: Aligos Therapeutics (ALGS) and Vertex Pharmaceuticals (VRTX) - The Globe and Mail

Jul 08, 2026

H.C. Wainwright reiterates Aligos Therapeutics stock rating at buy By Investing.com - Investing.com South Africa

Jul 08, 2026

Aligos commences dosing in Phase II trial for chronic hepatitis B treatment - MSN

Jul 08, 2026

Jul 07, 2026

Aligos Therapeutics stock is trending overnight: Here's what's going on with ALGS stock - MSN

Jul 07, 2026

H.C. Wainwright Maintains Aligos Therapeutics(ALGS.US) With Buy Rating, Maintains Target Price $50 - Moomoo

Jul 07, 2026

symbol__ Stock Quote Price and Forecast - CNN

Jul 07, 2026

Aligos Therapeutics Secures $25M Upfront Payment in Licensing De - GuruFocus

Jul 07, 2026

Aligos Therapeutics Stock Is Trending Overnight: Here's What's Going On With ALGS Stock - Benzinga

Jul 07, 2026

Jul 06, 2026

Aligos receives $25M upfront payment from China licensing deal - Investing.com UK

Jul 06, 2026

Aligos Therapeutics' Shares Rally Following $25M Payment From Xiamen Amoytop Biotech - Moomoo

Jul 06, 2026

Aligos Therapeutics stock jumps on $25M China licensing deal By Investing.com - Investing.com South Africa

Jul 06, 2026

Why is Aligos Therapeutics stock surging today? By Investing.com - Investing.com Canada

Jul 06, 2026

Aligos Therapeutics Receives Upfront Payment of $25M USD from the Exclusive License Deal of Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection - Investing News Network

Jul 06, 2026

Aligos receives $25M upfront payment from China licensing deal By Investing.com - Investing.com Nigeria

Jul 06, 2026

Aligos Therapeutics stock jumps on $25M China licensing deal - Investing.com

Jul 06, 2026

China grants breakthrough status to Aligos’ HBV drug after $25M deal - Stock Titan

Jul 06, 2026

Jul 02, 2026

ALGS News | ALIGOS THERAPEUTICS INC (NASDAQ:ALGS) - ChartMill

Jul 02, 2026

Jul 01, 2026

Discipline and Rules-Based Execution in ALGS Response - Stock Traders Daily

Jul 01, 2026

Jun 29, 2026

Form 4 Aligos Therapeutics Inc For: 29 June By Investing.com - Investing.com Nigeria

Jun 29, 2026

Form 4 Aligos Therapeutics Inc For: 29 June - Investing.com India

Jun 29, 2026

Aligos Therapeutics (ALGS) director granted 5,860 stock options at $5.50 - Stock Titan

Jun 29, 2026

Aligos Therapeutics (ALGS) director granted 5,860 stock options at $5.50 strike - Stock Titan

Jun 29, 2026

Aligos Therapeutics (ALGS) director granted 5,860 options at $5.50 strike - Stock Titan

Jun 29, 2026

Director at Aligos (ALGS) granted option on 5,860 common shares - Stock Titan

Jun 29, 2026

Aligos Therapeutics (ALGS) director gets 5,860-share stock option grant - Stock Titan

Jun 29, 2026

Aligos Therapeutics (ALGS) director receives stock options for 5,860 shares at $5.50 - Stock Titan

Jun 29, 2026

Aligos Therapeutics, Inc.(NasdaqCM:ALGS) added to Russell Microcap Value Benchmark Index - marketscreener.com

Jun 29, 2026

Aligos Therapeutics, Inc.(NasdaqCM: ALGS) added to Russell 3000E Index - marketscreener.com

Jun 29, 2026

Aligos Therapeutics, Inc. Actuals & Estimates (NASDAQ:ALGS) - TradingView

Jun 29, 2026

Aligos Therapeutics, Inc.(NasdaqCM: ALGS) added to Russell Microcap Index - marketscreener.com

Jun 29, 2026

Jun 28, 2026

Aligos Therapeutics, Inc.(NasdaqCM: ALGS) added to Russell 3000E Value Benchmark - marketscreener.com

Jun 28, 2026

Jun 26, 2026

Aligos Therapeutics Shareholders Approve Directors and Governance Changes - TipRanks

Jun 26, 2026

Aligos Therapeutics (ALGS) shareholders approve ESPP changes and annual say-on-pay - Stock Titan

Jun 26, 2026

Enterprise value to EBIT forward of Aligos Therapeutics, Inc. – NASDAQ:ALGS - TradingView

Jun 24, 2026

Enterprise value to revenue forward of Aligos Therapeutics, Inc. – NASDAQ:ALGS - TradingView

Jun 24, 2026

Enterprise value to EBITDA forward of Aligos Therapeutics, Inc. – NASDAQ:ALGS - TradingView

Jun 24, 2026

Price to book forward of Aligos Therapeutics, Inc. – NASDAQ:ALGS - TradingView

Jun 24, 2026

Price to earnings forward of Aligos Therapeutics, Inc. – NASDAQ:ALGS - TradingView

Jun 24, 2026

Lawrence M. Blatt Discloses Investment at Aligos Therapeutics with 5.6% Stake - TradingView

Jun 24, 2026

Aligos Therapeutics (NASDAQ: ALGS) CEO discloses 5.6% stake in Schedule 13D filing - Stock Titan

Jun 24, 2026

Jun 23, 2026